NDC Compounded Drug 73702-202-03 Fentanyl
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Fentanyl
NDC crossover of Fentanyl Citrate with NDC 73702-202 a human compounded drug with other similar products matching the same substance name (Fentanyl) and the same administration route (intravenous) or dosage form (injection, solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70214-3020-1 | Fentanyl 1,500mcg Per 30ml | Fentanyl | 30 mL in 1 SYRINGE | Injection, Solution | Intravenous | Providence Infusion Hospital Services |
70324-327-01 | Fentanyl In 0.9% Sodium Chloride | Fentanyl | 100 mL in 1 BAG | Injection, Solution | Intravenous | Sterrx Llc |
70324-327-02 | Fentanyl In 0.9% Sodium Chloride | Fentanyl | 250 mL in 1 BAG | Injection, Solution | Intravenous | Sterrx Llc |
73702-202-02 | Fentanyl Citrate | Fentanyl Citrate | 100 mL in 1 BAG | Injection, Solution | Intravenous | Wells Pharma Of Houston |
73702-202-15 | Fentanyl Citrate | Fentanyl Citrate | 5 mL in 1 SYRINGE | Injection, Solution | Intravenous | Wells Pharma Of Houston |
Frequently Asked Questions
What is the NDC number assigned to Fentanyl Citrate?
Fentanyl Citrate was assigned by its manufacturer with NDC product code 73702-202. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Fentanyl Citrate?
The NDC package code 73702-202-03 was assigned to a 250 mL in 1 BAG of fentanyl administered intravenous via injection, solution.
Who manufactures this product?
Fentanyl Citrate is manufactured by an outsourced facility and labeled by Wells Pharma Of Houston. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 5 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by PROVIDENCE INFUSION HOSPITAL SERVICES, SterRx LLC and Wells Pharma of Houston with NDC product codes 70214-3020-1, 70324-327-01, 70324-327-02, 73702-202-02 and 73702-202-15.